Creative Medical Technology Holdings, Inc.
CELZ • NASDAQ
Creative Medical Technology Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Timothy Warbington, with a market cap of $7.3M.
CEOTimothy Warbington
Next Earnings
Upcoming earnings announcement for Creative Medical Technology Holdings, Inc.
Date
Friday, May 8, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 11 earnings reports for Creative Medical Technology Holdings, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 7, 2025 | Q3 2025 | -$0.48Est: -$0.41 | -17.1% | - | — |  10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.48Est: -$0.63 | +23.8% | - | — | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.83Est: -$0.52 | -59.6% | $3.0K | — | 10-Q |
| Mar 14, 2025 | Q4 2024 | -$1.12Est: -$0.63 | -77.8% | $3.0K | — | 10-K/A |
| Nov 8, 2024 | Q3 2024 | -$0.75Est: -$0.85 | +11.8% | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$1.11Est: -$0.84 | -32.1% | $8.0K | — | 10-Q |
| May 10, 2024 | Q1 2024 | -$0.73Est: -$1.15 | +36.5% | - | — | — |
| Mar 22, 2024 | Q4 2023 | -$1.21Est: -$1.13 | -7.1% | $3.0K | — | — |
| Nov 14, 2023 | Q3 2023 | -$1.04Est: -$0.86 | -20.9% | $6.0K | — | — |
| Aug 11, 2023 | Q2 2023 | -$0.78 | — | - | — | — |
| May 12, 2023 | Q1 2023 | -$0.07Est: -$0.83 | +91.6% | -Est: $10.0K | -100.0% | — |